“Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market”
April 12, 2026
“Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs.
The two companies have worked together since 2023.
Insilico’s CEO, Alex Zhavoronkov, said Eli Lilly has a competitive edge in certain aspects of AI…”